Natalie Kirilcuk

Dr. Tyler Johnson--a clinical associate professor of medicine and oncology at Stanford University Medical School--is a physician, author, educator, and humanitarian. A medical oncologist, Dr. Johnson sees patients with all types of gastrointestinal malignancies and particularly focuses on patients with neuroendocrine tumors, colon cancer, and pancreas cancer.Dr. Johnson served for many years as a leader of the Stanford Hospital in-patient oncology services and helped launch the hospital's first direct care inpatient service, med 12. He is also responsible for helping respond to the surge of patients that came with the pandemic and its aftermath.Dr. Johnson views the practice of medicine largely as an educational endeavor.

Dr. Ronald Levy is a distinguished medical oncologist and lymphoma specialist based in Palo Alto, California, serving as the Robert and Helen K. Summy Professor in the School of Medicine. With a robust educational background from esteemed institutions such as Stanford University and Harvard University, he has made significant contributions to cancer immunotherapy and has received numerous prestigious awards for his research and clinical work. Dr. Levy's expertise encompasses a range of treatments for lymphomas, and he is actively involved in advancing the field through clinical trials and innovative therapies. His commitment to patient care and groundbreaking research has positioned him as a leading figure in oncology, particularly in the development of dendritic cell vaccines and immunotherapy strategies. Generated from the website

Eugene Shkolyar, MD is a urologic oncologist who specializes in treating patients with bladder, prostate, kidney, and testis cancers. He is a clinical assistant professor in the Department of Urology at the Stanford School of Medicine.Dr. Shkolyar has expertise in open, endoscopic, and robotic surgery and in caring for patients with complex urologic oncology needs. Dr. Shkolyar is actively engaged in translational research, with a particular interest in integrating artificial intelligence into bladder cancer treatment and the development of novel biomarkers for cancer detection. His commitment to continual innovation ensures that his patients have access to the latest and most effective treatment options.Dr.